Curaleaf says it does not comment on market speculation amid reports it may be interested in Cronos

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

Curaleaf Holdings Inc. said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company...

Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CA:CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

... Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 3. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Cronos Group stock rises in premarket as it confirms merger talksCronos Group Inc. stock is up nearly 6% in premarket trades on Friday after the Canadian cannabis company said it’s reviewing unsolicited indications of...
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »

Bed Bath & Beyond investors have spent $200 million trading 'worthless' shares — will this holding company help them?Bed Bath & Beyond investors have spent $200 million trading ‘worthless’ shares — will this holding company help them?
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »